Does Spironolactone Cause Hyponatremia?

Spironolactone can cause hyponatremia, though it does so less predictably and less frequently than thiazide diuretics. The drug’s most notorious electrolyte side effect is hyperkalemia (high potassium), so the risk of low sodium often catches both patients and clinicians off guard. In studies of heart failure patients, roughly a third had low sodium levels, and spironolactone use was independently linked to that finding. The story gets more nuanced when you factor in dose, what other drugs are on board, and who is taking it.

Why Spironolactone Is Not the Usual Suspect for Low Sodium

Diuretics are a leading cause of hyponatremia overall, but the risk is not spread evenly across the class. Textbook pharmacology draws a clear line: loop diuretics and thiazides are the ones most associated with sodium-wasting and fluid imbalances, while potassium-sparing agents like spironolactone, amiloride, and eplerenone are primarily flagged for the opposite electrolyte problem, hyperkalemia, along with metabolic acidosis.¹ This is why most drug reference sheets list hyperkalemia as spironolactone’s major electrolyte concern and barely mention hyponatremia.

The mechanism makes intuitive sense. Spironolactone blocks aldosterone, a hormone that tells the kidneys to hold on to sodium and excrete potassium. When aldosterone is blocked, more sodium leaves the body in urine while potassium is retained. In theory, this sodium loss could lower blood sodium. In practice, healthy kidneys compensate well, and the sodium-lowering effect is usually modest enough that blood levels stay in the normal range. The problem arises when the kidneys are already stressed, when the dose is high, or when other sodium-lowering drugs are stacked on top.

What the Data Actually Show

The clearest evidence comes from heart failure populations, where spironolactone is prescribed frequently and where hyponatremia is already common because of the disease itself. A study of 565 hospitalized heart failure patients found that about a third were hyponatremic. In the initial analysis, patients taking spironolactone were more likely to have low sodium than those who were not. When the researchers controlled for other factors, spironolactone doses of 50 to 100 mg remained independently associated with hyponatremia, as did higher furosemide doses, increasing age, diabetes, and alcohol consumption.²

A separate analysis of ambulatory heart failure patients confirmed the pattern from a different angle: spironolactone use was independently associated with hyponatremia even after accounting for other common culprits like diabetes, low blood pressure, and anemia.³ That this showed up in outpatients, not just in the hospital setting, matters. It suggests the association is not simply an artifact of acutely ill patients on aggressive diuretic regimens.

Still, the absolute numbers in smaller studies look less alarming. One heart failure clinic tracked patients on spironolactone for a year and reported that just two patients developed hyponatremia, while six developed hyperkalemia.⁴ Hyperkalemia was three times more common in that cohort. That ratio, hyperkalemia showing up far more often than hyponatremia, aligns with the textbook expectation and is probably closer to what doctors see in routine outpatient practice when doses are kept reasonable.

Dose Makes a Real Difference

One of the clearest takeaways from the research is that spironolactone-related hyponatremia is dose-dependent. In the large heart failure study, patients on 25 mg of spironolactone had significantly lower rates of hyponatremia than those on 50 or 100 mg.² The 25 mg dose is the starting point for most heart failure patients and many people taking spironolactone for resistant hypertension. Higher doses are sometimes used for conditions like liver cirrhosis with ascites, where fluid overload is severe and more aggressive diuretic therapy is needed. Those patients face a dual risk: the disease itself promotes dilutional hyponatremia, and the higher spironolactone dose may push sodium levels further down.

For people taking spironolactone at lower doses for blood pressure or off-label uses like acne or hair loss, the risk profile looks different. Dermatologists commonly prescribe 50 to 200 mg daily for hormonal acne and androgenetic alopecia, doses that sometimes overlap with the range associated with hyponatremia in heart failure patients. But these patients are generally younger, have normal kidney function, and are not on other diuretics. Context matters enormously: the same 100 mg dose carries a very different risk in a 28-year-old with clear kidneys than in a 75-year-old with heart failure and borderline renal function.

Combination Therapy Amplifies the Risk

Spironolactone is rarely the only diuretic on a patient’s medication list. In heart failure, it is almost always paired with a loop diuretic like furosemide. In resistant hypertension, it may be added on top of a thiazide. These combinations are where the hyponatremia risk really climbs.

The heart failure study found that patients taking both furosemide and spironolactone were more likely to be hyponatremic than those on either drug alone.² High doses of both drugs compounded the effect: furosemide at 250 to 500 mg daily alongside spironolactone at 50 to 100 mg was the highest-risk combination identified. This makes pharmacological sense. Loop diuretics cause the kidneys to dump sodium directly, and when aldosterone blockade from spironolactone is layered on, the kidneys lose two of their main mechanisms for retaining sodium.

A nationwide cohort study focused on hypertension patients taking thiazides found an even more striking pattern. When spironolactone was added to a thiazide regimen, the risk of developing hyponatremia climbed. Adding desmopressin, a synthetic hormone that promotes water retention, on top of a thiazide-plus-spironolactone regimen pushed the risk of hospitalization for hyponatremia up by four to nearly seven times.⁵ Desmopressin is sometimes prescribed for nighttime urination or bleeding disorders, so the triple combination is not common, but it illustrates how quickly sodium homeostasis can unravel when multiple drugs push in the same direction.

A study of hospitalized patients with confirmed hypotonic hyponatremia looked at how the biochemical picture differs when spironolactone is the only diuretic versus when it is paired with furosemide. The spironolactone-alone group had better kidney function and was more likely to have hypertension as their underlying condition, while the combination group had worse kidney function and higher rates of heart failure.⁶ The practical implication is that the underlying disease burden, not just the drug itself, shapes how much trouble a given regimen causes.

Who Faces the Greatest Risk

Several patient characteristics consistently show up as independent risk factors for developing hyponatremia while on spironolactone:

Older age: Aging kidneys are less efficient at concentrating urine and compensating for sodium losses. The large heart failure study identified increasing age as an independent risk factor even after adjusting for dose and other drugs.²
Diabetes: Both studies of heart failure patients flagged diabetes as independently associated with hyponatremia during spironolactone use.³ High blood sugar itself can cause a misleading sodium reading, but true hyponatremia is also more common in diabetic patients due to kidney and hormonal effects.
Alcohol consumption: Alcohol suppresses a hormone called vasopressin in the short term but can cause the body to overcompensate afterward, leading to inappropriate water retention. The heart failure study identified alcohol consumption as an independent risk factor for hyponatremia.²
Liver cirrhosis: Patients with advanced liver disease often require high doses of spironolactone to control ascites. Their livers cannot metabolize the drug efficiently, their kidneys are compromised, and the disease itself promotes water retention and dilutional hyponatremia. This population sits at the intersection of nearly every risk factor.
Heart failure itself: Reduced cardiac output triggers the body to retain water disproportionately to sodium, creating a baseline tendency toward low sodium that diuretics can worsen.

Younger, otherwise healthy patients taking spironolactone at low to moderate doses for conditions like acne, hirsutism, or hair thinning fall into a genuinely different risk category. Clinically significant hyponatremia in this group is uncommon enough that routine sodium monitoring is not standard practice in dermatology, though some clinicians check a baseline metabolic panel and recheck after a few weeks.

Switching from a Thiazide to Spironolactone

One question that comes up in practice is whether a patient who developed hyponatremia on a thiazide diuretic can safely switch to spironolactone. Thiazides are well established as the diuretic class most likely to drop sodium levels, especially chlorthalidone, which has a longer duration of action and a particularly strong association with hyponatremia. A preliminary study looked at 14 patients who had experienced chlorthalidone-induced hyponatremia and were subsequently started on spironolactone. Eight of them tolerated spironolactone without developing low sodium, while six developed hyponatremia on both drugs.⁷

The numbers are too small to draw firm conclusions, but the fact that more than half of these susceptible patients tolerated the switch is encouraging. It suggests that the mechanism by which thiazides lower sodium does not perfectly overlap with how spironolactone does it. Thiazides primarily impair the kidney’s ability to dilute urine by blocking sodium reabsorption at a specific site in the kidney tubule. Spironolactone’s mechanism is broader, working through aldosterone blockade in the collecting duct, and the resultant sodium loss is generally milder. A patient whose sodium dropped on chlorthalidone is not automatically going to have the same problem on spironolactone, but close monitoring during the first few weeks of the switch is warranted.

The Hyperkalemia and Hyponatremia Seesaw

An underappreciated aspect of spironolactone’s electrolyte profile is that hyperkalemia and hyponatremia can coexist. Aldosterone normally drives sodium retention and potassium excretion; blocking it does both in reverse. In the heart failure clinic study that followed patients for a year, some of those who developed hyponatremia also had elevated potassium levels.⁴ The hospitalized hyponatremia study confirmed that patients on spironolactone alone had higher potassium levels compared to those not on diuretics.⁶

This is clinically important because the management of hyponatremia sometimes involves giving normal saline, which contains sodium chloride. If a patient also has high potassium, the treatment approach gets more complicated, and clinicians have to balance two electrolyte problems moving in opposite directions. In patients on spironolactone, a metabolic panel that only checks sodium or only checks potassium misses half the picture.

How Hyponatremia Feels and When to Worry

Mild hyponatremia, where sodium drops just below the normal range of about 135 milliequivalents per liter, often causes no noticeable symptoms. You might feel slightly more fatigued than usual or a bit off, but nothing specific enough to send you to a doctor. As levels fall further, symptoms become more recognizable: nausea, headache, confusion, muscle cramps, and unsteadiness. Severe hyponatremia, generally below 120 milliequivalents per liter, can cause seizures, loss of consciousness, and in extreme cases brain swelling.

For people on spironolactone, especially at higher doses or in combination with other diuretics, a few practical signals should prompt a check with your prescriber. Persistent nausea or vomiting that appeared after starting or increasing the dose is one. Feeling confused or mentally foggy when you were fine before is another. Muscle cramps that are new or worse than usual, particularly if they are not explained by exercise or dehydration, deserve attention. None of these symptoms are specific to hyponatremia, but in someone taking a drug that can lower sodium, they should not be brushed off.

Monitoring in Practice

Guidelines for heart failure generally recommend checking a metabolic panel within one to two weeks of starting spironolactone or changing the dose, then periodically afterward. In practice, monitoring is inconsistent. This matters because spironolactone-related electrolyte disturbances tend to develop within the first few weeks and can creep up gradually, making them easy to miss if blood work is not checked on schedule.

For patients taking spironolactone for conditions outside of heart failure, monitoring habits vary widely. Cardiologists and nephrologists tend to check labs regularly because they are already tracking kidney function and electrolytes for other reasons. Dermatologists, who prescribe spironolactone frequently for skin and hair conditions, often check a baseline panel and a follow-up at four to six weeks, then taper the frequency if results look stable. Whether this is sufficient depends on the individual: a young patient with normal kidney function on 50 mg daily is a very different proposition from a 60-year-old on 200 mg with mild kidney impairment. If you are on spironolactone and your prescriber has not checked your electrolytes recently, asking for a lab draw is a reasonable conversation to have, especially if your dose has changed or you have started a new medication that could affect sodium or potassium.

Spironolactone and Fluid Intake

One factor that does not get enough attention in discussions of drug-induced hyponatremia is how much water a patient drinks. Spironolactone causes mild sodium loss through the kidneys. If you pair that with excessive water intake, you dilute whatever sodium remains in the bloodstream. This is not unique to spironolactone, but it becomes relevant because people taking diuretics sometimes assume they need to drink more water to compensate for urine output. For most patients on moderate spironolactone doses, drinking to thirst rather than forcing extra fluid is the better approach. The people most vulnerable to this compounding effect are elderly patients, who tend to have a blunted thirst mechanism and may follow well-intentioned but misguided advice to drink eight or more glasses of water per day regardless of actual need.

Excessive water intake is also worth flagging in the context of exercise. Endurance athletes and people who exercise heavily sometimes develop what is called exercise-associated hyponatremia from drinking too much water during prolonged activity. If that person also happens to be on spironolactone, the margin for maintaining normal sodium levels shrinks further. The fix is not to avoid exercise but to be mindful about fluid replacement: using drinks that contain electrolytes rather than plain water during long or intense sessions, and not forcing fluid beyond what thirst dictates.